Cardiovascular Diagnosis and Therapy · Published 2026-06-01 · DOI 10.21037/cdt-2025-1-626
Jingjiang Pi, Liang Geng, Chenghui Fan, Jing Xu, Xingxu Wang, Qi Zhang, Wei Wei
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Pi, J., Geng, L., Fan, C., et al. (2026). Plasma alarmin S100A8/A9 serves as a potential biomarker of major adverse cardiovascular events after acute myocardial infarction. Cardiovascular Diagnosis and Therapy. https://doi.org/10.21037/cdt-2025-1-626